3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
2
Uterine Cervical Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Rectal Neoplasms
1
Rectal Diseases
1
Neoplasms
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Colonic Diseases
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Brenner Tumor
1
Interventions
TIC10 compound
4
trametinib
3
dabrafenib
3
vorasidenib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
defactinib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vincristine
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Nuclear Medicine Department, Hospital
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Glioma
×
Bevacizumab
×
Clear all
No trials found.